PATENT CLAIM ANALYSIS

Application Number: 16072382
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["800", "008000"]

Abstract:
The invention provides methods of treating schizophrenia in a subject, including for example, administering to the subject an agent that inhibits expression or activity of a C4A polynucleotide or polypeptide. The invention also provides methods of identifying a subject having or at risk of developing schizophrenia involving measuring or detecting an alteration in the level, copy number, and/or sequence of complement component C4A or complement component C4B relative to a reference.

Claim (Index 26):
The method of any one of  claims 13 - 18 , wherein the subject is human.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 95.0
- Lexical Diversity: 1.60417
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15029224', '14388791', '10107604', '10222945', '10150821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.610156296069891
- 35 USC 102 Novelty (BERT): 0.5015061477758336
- Combined Prediction Score: 0.5992912812404853
- Mean Citation Score: 207.578086
- Max Citation Score: 218.4893
- Similarity Product: 122.89134957960844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test